PERSPECTIVE THERAPEUTICS INC
CATXNYSE AMERICAN🏆 #3388 by market capEarnings Nov 9US Equity
$2.62▲ $0.13 (+4.80%)
🌙 After hours$2.58▼ 1.53%Regular close · extended-hours price shownTrack CATX
Get earnings, price moves & breaking news on Telegram
24h▲ 4.8%
7d▲ 0.2%
14d▼ 3.0%
30d▼ 16.8%
ytd▼ 4.7%
1y▼ 24.1%
🏦Market Cap
$299M
Small Cap
📈Revenue Growth (YoY)
-100.0%
Declining
📊Gross Margin
-419.4%
Thin
💵FCF Margin
-33111.2%
Thin
⚖️P/S Ratio
816.4x
Expensive
Otter Score
48
Weak
PERSPECTIVE THERAPEUTICS INC
CATXAnalyst Ratings
Price
$2.62
Total
12
Raised
0
Lowered
1
Avg PT
$11.00
H / L
$11 / $11
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-09-15 | — | — |
B of A Securities | Reiterated | Neutral | 2026-08-14 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-08-11 | $16.00 | +510.70% |
BTIG | Reiterated | Buy | 2026-05-05 | $14.00 | +434.40% |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-23 | — | — |
UBS | Reiterated | Buy | 2026-03-18 | $7.00 | +167.20% |
B. Riley Securities | Reiterated | Buy | 2026-03-18 | — | — |
RBC Capital | Reiterated | Outperform | 2026-03-17 | $3.00 | +14.50% |
Truist Securities | Reiterated | Buy | 2025-05-14 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-11-22 | $22.00 | +739.70% |
Jones Trading | Reiterated | Buy | 2024-05-16 | — | — |
Maxim Group | Downgraded | Buy → Hold | 2018-11-08 | — | — |
Institution
Wedbush
Reiterated · Outperform · 2026-09-15
—
—
B of A Securities
Reiterated · Neutral · 2026-08-14
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-11
$16.00
+510.70%
BTIG
Reiterated · Buy · 2026-05-05
$14.00
+434.40%
HC Wainwright & Co.
Reiterated · Buy · 2026-03-23
—
—
UBS
Reiterated · Buy · 2026-03-18
$7.00
+167.20%
B. Riley Securities
Reiterated · Buy · 2026-03-18
—
—
RBC Capital
Reiterated · Outperform · 2026-03-17
$3.00
+14.50%
Truist Securities
Reiterated · Buy · 2025-05-14
—
—
Oppenheimer
Reiterated · Outperform · 2024-11-22
$22.00
+739.70%
Jones Trading
Reiterated · Buy · 2024-05-16
—
—
Maxim Group
Downgraded · Buy → Hold · 2018-11-08
—
—
One row per institution · price target from the firm's latest published target